Neuland Laboratories Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹641.58 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 17.35 per cent from ₹776.25 crore. This corresponds to a year-on-year *(YoY) growth of 119.16 per cent.
Operating Profit
Operating Profit stands at ₹222.89 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 27.48 per cent from ₹307.33 crore. This corresponds to a year-on-year *(YoY) growth of 546.25 per cent.
PBDT
PBDT stands at ₹224.40 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 28.21 per cent from ₹312.58 crore. This corresponds to a year-on-year *(YoY) growth of 494.28 per cent.
Profit Before Tax
Profit Before Tax stands at ₹197.84 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 31.18 per cent from ₹287.49 crore. This corresponds to a year-on-year *(YoY) growth of 1,026.01 per cent.
Net Profit
Net Profit stands at ₹147.67 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 30.56 per cent from ₹212.67 crore. This represents a 962.37 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Neuland Laboratories Ltd News
Neuland Laboratories Ltd Earnings
- YOY
- QOQ
Neuland Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Neuland Laboratories Ltd Research Reports
Neuland Laboratories Ltd Financial Reports
Neuland Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Neuland Labs. | 0.04% | -2.58% | 20.97% | 36.96% | 79.23% | 74.98% |
| Emcure Pharma | 0.06% | -1.40% | -3.63% | 7.52% | 27.46% | 29.70% |
| Wockhardt | 0.18% | 4.17% | 2.20% | 7.61% | 40.07% | 33.64% |
| Sai Life | 1.40% | -1.10% | 13.11% | 28.86% | 45.98% | 78.43% |
| Rubicon Research | -3.67% | -3.13% | 9.27% | 76.74% | 118.55% | 172.05% |
| Piramal Pharma | -1.61% | -3.97% | 8.25% | 19.35% | 33.14% | 11.56% |
| Acutaas Chemical | 4.21% | 2.85% | -1.98% | 9.99% | 52.96% | 135.68% |
Company Info
Company Information
Chairman & Exec. Director : D R Rao
Vice Chairman / Executive Director / WTD : D Sucheth Rao
Non Independent ED / MD / CEO / Promoter : D Saharsh Rao
Independent Non Exe. Director : Homi R Khusrokhan
Independent Non Exe. Director : P R Menon
Independent Non Exe. Director : Sugata Sircar
Independent Non Exe. Director : Pallavi Joshi Bakhru
Independent Non Exe. Director : Ravi Gopinath
Non Executive Director : Mauricio Futran
Company Sec. & Compli. Officer : Sarada Bhamidipati